Metastatic Renal Cell Carcinoma

Also known as: Metastatic Renal cell carcinoma

DrugDrug NameDrug Description
DB00041AldesleukinA recombinant analog of interleukin-2 used to induce an adaptive immune response in the treatment of renal cell carcinoma.
DB00112BevacizumabA monoclonal anti-vascular endothelial growth factor antibody used in the treatment of many cancer types in combination with other antineoplastics.
DB00603Medroxyprogesterone acetateA progestin used as a contraceptive and in the treatment of secondary amenorrhea, abnormal uterine bleeding, pain from endometriosis, endometrial and renal carcinomas, paraphilia in males, and GnRH-dependent precocious puberty.
DrugDrug NameTargetType
DB00041AldesleukinInterleukin-2 receptor subunit betatarget
DB00041AldesleukinInterleukin-2 receptor subunit alphatarget
DB00041AldesleukinCytokine receptor common subunit gammatarget
DB00041AldesleukinProstaglandin G/H synthase 2enzyme
DB00041AldesleukinCytosolic phospholipase A2enzyme
DB00041AldesleukinCytochrome P450 3A4enzyme
DB00041AldesleukinXanthine dehydrogenase/oxidaseenzyme
DB00041AldesleukinCytochrome P450 2E1enzyme
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00112BevacizumabComplement C1r subcomponenttarget
DB00112BevacizumabComplement C1q subcomponent subunit Atarget
DB00112BevacizumabComplement C1q subcomponent subunit Btarget
DB00112BevacizumabComplement C1q subcomponent subunit Ctarget
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00112BevacizumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00112BevacizumabVascular endothelial growth factor Atarget
DB00603Medroxyprogesterone acetateProgesterone receptortarget
DB00603Medroxyprogesterone acetateEstrogen receptor alphatarget
DB00603Medroxyprogesterone acetateCytochrome P450 3A4enzyme
DB00603Medroxyprogesterone acetateCytochrome P450 2C8enzyme
DB00603Medroxyprogesterone acetate3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2enzyme
DB00603Medroxyprogesterone acetateCytochrome P450 2C9enzyme
DB00603Medroxyprogesterone acetateCytochrome P450 3A1enzyme
DB00603Medroxyprogesterone acetateSerum albumincarrier
DB00603Medroxyprogesterone acetateP-glycoprotein 1target
DB00603Medroxyprogesterone acetateGABA-A receptor (anion channel)target
DrugDrug NamePhaseStatusCount
DB08947Iopamidol0Recruiting1
DB05182AS14091Completed1
DB00041Aldesleukin1Recruiting1
DB00112Bevacizumab1Completed2
DB08875Cabozantinib1Recruiting1
DB00531Cyclophosphamide1Recruiting1
DB00531Cyclophosphamide1Withdrawn1
DB11651Dactolisib1Completed1
DB01590Everolimus1Completed2
DB01099Flucytosine1Active Not Recruiting1
DB01073Fludarabine1Recruiting1
DB14865Human interleukin-21Withdrawn1
DB06186Ipilimumab1Recruiting2
DB09035Nivolumab1Recruiting3
DB06589Pazopanib1Active Not Recruiting1
DB06589Pazopanib1Completed1
DB08913Radium Ra 223 Dichloride1Active Not Recruiting1
DB09566Radium Ra 223 Dichloride1Active Not Recruiting1
DB12813Radium Ra-2231Active Not Recruiting1
DB00398Sorafenib1Active Not Recruiting1
DB01268Sunitinib1Completed1
DB15331Vocimagene amiretrorepvec1Active Not Recruiting1
DB00041Aldesleukin1 / 2Active Not Recruiting1
DB00041Aldesleukin1 / 2Completed1
DB08875Cabozantinib1 / 2Recruiting1
DB00002Cetuximab1 / 2Recruiting1
DB01248Docetaxel1 / 2Recruiting1
DB01590Everolimus1 / 2Completed1
DB01590Everolimus1 / 2Recruiting1
DB05304Girentuximab1 / 2Completed1
DB01611Hydroxychloroquine1 / 2Active Not Recruiting1
DB09053Ibrutinib1 / 2Recruiting1
DB09570Ixazomib1 / 2Terminated1
DB09078Lenvatinib1 / 2Completed1
DB09035Nivolumab1 / 2Not Yet Recruiting1
DB13048PAC-11 / 2Not Yet Recruiting1
DB01229Paclitaxel1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Not Yet Recruiting1
DB09037Pembrolizumab1 / 2Recruiting3
DB023422-Methoxyestradiol2Completed1
DB04998AGRO1002Unknown Status1
DB00945Acetylsalicylic acid2Recruiting1
DB00640Adenosine2Recruiting1
DB00041Aldesleukin2Completed1
DB00041Aldesleukin2Unknown Status1
DB00126Ascorbic acid2Recruiting1
DB11595Atezolizumab2Active Not Recruiting1
DB11945Avelumab2Recruiting1
DB06626Axitinib2Active Not Recruiting1
DB06626Axitinib2Completed1
DB06626Axitinib2Recruiting2
DB06626Axitinib2Terminated1
DB00112Bevacizumab2Completed3
DB00112Bevacizumab2Recruiting1
DB00112Bevacizumab2Terminated1
DB00112Bevacizumab2Unknown Status1
DB00188Bortezomib2Terminated1
DB08875Cabozantinib2Active Not Recruiting1
DB08875Cabozantinib2Not Yet Recruiting1
DB08875Cabozantinib2Recruiting2
DB01101Capecitabine2Completed1
DB14917Ceralasertib2Recruiting1
DB00694Daunorubicin2Recruiting1
DB00997Doxorubicin2Completed2
DB00997Doxorubicin2Recruiting1
DB06486Enzastaurin2Completed1
DB01590Everolimus2Completed3
DB01590Everolimus2Terminated1
DB00099Filgrastim2Completed1
DB00441Gemcitabine2Completed2
DB00441Gemcitabine2Recruiting1
DB14865Human interleukin-22Terminated1
DB00034Interferon alfa-2a, Recombinant2Completed2
DB00105Interferon alfa-2b2Unknown Status1
DB06186Ipilimumab2Not Yet Recruiting1
DB06186Ipilimumab2Recruiting1
DB06186Ipilimumab2Withdrawn1
DB09570Ixazomib2Recruiting1
DB11740MK-17752Recruiting1
DB09035Nivolumab2Active Not Recruiting2
DB09035Nivolumab2Not Yet Recruiting1
DB09035Nivolumab2Recruiting4
DB09035Nivolumab2Withdrawn1
DB09074Olaparib2Recruiting2
DB06589Pazopanib2Active Not Recruiting2
DB06589Pazopanib2Completed3
DB06589Pazopanib2Recruiting1
DB06589Pazopanib2Terminated1
DB06589Pazopanib2Unknown Status1
DB00019Pegfilgrastim2Completed1
DB09037Pembrolizumab2Active Not Recruiting1
DB05578Ramucirumab2Completed1
DB15073Ribose2Recruiting1
DB14765Rivoceranib2Not Yet Recruiting1
DB00398Sorafenib2Completed3
DB00398Sorafenib2Recruiting2
DB00398Sorafenib2Terminated3
DB01268Sunitinib2Active Not Recruiting2
DB01268Sunitinib2Completed8
DB01268Sunitinib2Recruiting3
DB01268Sunitinib2Terminated2
DB01268Sunitinib2Unknown Status1
DB11760Talazoparib2Recruiting1
DB14227Technetium Tc-99m2Completed1
DB15232Telaglenastat2Active Not Recruiting1
DB06287Temsirolimus2Active Not Recruiting1
DB06287Temsirolimus2Completed1
DB13946Testosterone undecanoate2Completed1
DB11800Tivozanib2Completed1
DB15140Bempegaldesleukin3Recruiting1
DB08875Cabozantinib3Recruiting1
DB00531Cyclophosphamide3Completed1
DB06643Denosumab3Recruiting1
DB05928Dovitinib3Completed1
DB01590Everolimus3Completed1
DB14865Human interleukin-23Completed1
DB05258Interferon alfa3Completed1
DB06186Ipilimumab3Active Not Recruiting1
DB00603Medroxyprogesterone acetate3Completed1
DB09035Nivolumab3Active Not Recruiting1
DB09035Nivolumab3Recruiting2
DB00020Sargramostim3Completed1
DB00398Sorafenib3Completed2
DB00398Sorafenib3Unknown Status1
DB01268Sunitinib3Active Not Recruiting1
DB01268Sunitinib3Completed1
DB01268Sunitinib3Recruiting1
DB01268Sunitinib3Terminated1
DB01268Sunitinib3Unknown Status1
DB00399Zoledronic acid3Recruiting1
DB01590Everolimus4Completed2
DB01268Sunitinib4Terminated3
DB06589PazopanibNot AvailableCompleted2
DB01268SunitinibNot AvailableCompleted4
DB01268SunitinibNot AvailableRecruiting1